![](/img/cover-not-exists.png)
PRS9 COST OF COMMUNITY ACQUIRED PNEUMONIA (CAP) TREATMENT WITH KETEK (TELITHROMYCIN) VS CLARITHROMYCIN FROM PUBLIC PAYER PERSPECTIVE IN POLAND
P Kawalec, J Lis, J GierczynskiVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)67805-9
File:
PDF, 64 KB
english, 2005